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Di(I ,N~.cth~aoadcnosin©)5 '. 5'".P ,P.tetrapitosphate, ¢.(Ap,A), a fluorescent analog of Ap4A has bc©n synthesized by reaction of 2.¢hloroacetalde. 
hyde witlt Ap~A. At neutral p H this Ap~A analoll presents d~araeteristie maxima t 26~ and 274 nm, shoulders at ca 260 anti ,310 nnl and moderat~ 
fluorescence {,~,,, ~107 nm, 2,,, 410 nm), Enzymatic hydrolysis oF the phosphate backbone produced a slight hyperehromic effect but a notorious 
increase of the fluorescence emiision. Cytosolic ©xtracts fron~ adrenochromaffin t ssue as well as cultured chromaltin cells were able to split c(Ap, A) 
and catabolize the rcsultinj ¢.nucleotide moieties up to c-Ado, 
Ap,~A; Ap~A fluoctstcnt deriv~ttive; Ap4A splittin8 enzyme; Ectoenzyme; Chromafl~n cell 
I. INTRODUCTION 
The biochemistry of diadenosine polyphosphates, 
mainly Ap4A, has received increasing interest through- 
out recent years [1,2], however, their precise biological 
functions remain to be clearly understood. Roles as 
alarmone [3,4] or as inductor of DNA synthesis [1] have 
been proposed for Ap4A. Moreover the presence of  
Ap4A and Ap~A in human platelets [5-7] and of ApS-A 
and Ap4A in the secretory granules of chromaffin cells 
[8] suggest a potential implication of these dinucleotides 
in platelet and neurosecretory functions. On the other 
hand the strong inhibition of adenosine kinase by Ap4A 
[9] and its inhibitory effect on evoked catecholamine 
secretion [10] has been reported. 
Specific enzymes that split Ap4A, and can conse- 
quently modulate the cellular levels of this dinucleotide, 
have been isolated and studied from many biological 
sources [11,13]. The most sensitive methods to assay 
such enzymes involve the use of luminometric [14] and 
radiometric techniques [15]. 
The acquisition of fluorescent and enzymatically ac- 
tive derivatives of Ap4A would be of great interest in 
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order to open the study of Ap4A biochemistry through 
a new fluorimetric approach. The fluorescent etheno 
derivatives of common adenosine containing nucleo- 
tides (e.g. e-AMP, e-ADP, e-ATP or e-NAD+), ob- 
tained by reaction of 2-chloroacetaldehyde with 
adenine rings, have been useful fluorescent probes to 
study kinetic and binding properties of some kinases 
and dehydrogenases [16-18]. In this article we report 
the synthesis and some properties of  a fluorescent Ap4A 
derivative and show that this analog is efficiently 
catabolized by intact chromaffin cells and extracts from 
adrenomedullary tissue. 
2. MATERIALS AND METHODS 
2.1, Chemical 
~-ATP, ~.ADP, e-AMP, c-Ado and Ap4A were from Sigma (St. 
Louis, MO, USA), 2.chloroacetaldehyde was from Merck (Darm- 
stadt, Germany) and C, durissus phosphodiesterase was from Boehr- 
inger (Mannheim, Germany), Methanol and salts used for HPLC 
were of HPLC grade from Merck. All other products were reagent 
grade. 
2.2. HPLC 
The chromatographic system was made up of a M-510 pump, a 
U6K injector, a 440 UV dectector at a fixed wavelength of 254 rim, a 
420 AC fluorescent detector at X~xe 300 nm and Xc., 400 nm, a/¢Bon- 
dapack C-18 column (300 × 4 ram, 10 t¢ particle size) and a Guard 
Pak module packed with C-18 material to protect he analytical col- 
umns, all from Waters Assoc, (Milford, MA, USA). Chromatograms 
were obtained by an HP 3390 A integrator (Hewlett.Packard, Avon- 
dale, CA, USA) and by a Pharmacia LKB recorder (Uppsala, 
Sweden). A UV and fluorescence detector were connected in this 
order. Occasionally a Liehrosorb RP 18 column (250 x 4 mm, I0 # 
particle size) purcllased from Kontron (Zurich, Switzerland) was us- 
ed. The mobile phase was composed of 0.1 M KH2 PO4, I0% 
methanol, pH 6.0 and was pumped at a flow rate of 1.5 ml/min 
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througl~ the ~Bondat~¢k C.II~ column or m 1.0 ml/min throullh lh~ 
L i¢l~rosorb RP I # ~olumn. Preparation or the mobile phase and st.n- 
dards was as described pr~vioudy 1191. The eludon order or etheno 
derivatives was ~.ATP. ~.^DP, ~-^M P. ~-(^p~A} and ~-Ado, Sep-pak 
kccell QMA ¢~rtridl~es (anion e~ch{~nl!©) used in the preparative 
separallon of #,(AI~A) were from ~alers, 
2.3, $/,vtcrrcaeop.v 
Ultraviolet anti uncorrected fluorescence, spectra were obtained by 
m~ans of a DU.40 spectrophotomcter tBeekman, $. Ram6n, CA. 
USA) and a F.2000 spectrofluorimeter (Hitachi, Tokyo, JapanJ. 
Spectra or ( . tArA)  were recorded in solutions of  20 mM potassium 
phosphate buffer, 4 mM MIICI=, pH 7.0 or :50 mM Tris.HCI. 4 mM 
MllCl~, pH 8.0 (I.0 rnl) in quartz cuve.ttes (Sl|ma), Then, I ul contain. 
ins 0,6 mU of C, D~rtMus pltospltodiesterase was added and spectra 
were again recorded after the corn pletion of enzymatic hydrolysis, 
2.4, Biolotli3¢#l ea'tra¢l$, ~¢I/ eultur¢~ attd ¢nr..Ym~ a.~tays 
Metabolite, fre¢ c~'tOsOliC extracts from bovine adrenal metlull-'t, 
were prepared as described [8,191, Reaction mixtures to monitor en. 
zymadc degradation of (.(Ap.~A) contained SO mM Tris.HCI. 4 mM 
MllCl= pH 8.0, 10/~M (.(Ap~A) and ~0#1 of extract in a final volume 
of 1.0 ml and were incubated at 37"C. At the required times 12S #1 all. 
q nots were taken up, heated for 2 rain in a boiling water bath to stop 
enzym.', action attd centrifuged to eliminate precipitated protein. 
10-50#1 aliquots or the clear supcrnalant were processed byreversed- 
phase HPLC accordinll to section 2.2. 
Chromaffin cell cultures were performed as previously described 
120,21], To monitor the ectoenzymatic desradaflon of e-(Ap4A), 3x 
I0 a cells/well were incubated at 3"/°<2 in 03 ml of Locke's olution 
containing 2-10 #MI e-(ApaA), At the required times $0 jd.aliquots 
were taken up and processed by reversed.phase HPLC according to 
section 2,2, 
3. RESULTS AND DISCUSSION 
3.1. Synthesis and chromatographic purification of 
e.fAp4A) 
The reaction conditions were similar to those describ- 
ed for the synthesis of etheno derivatives of adenosine 
and related common nucleotides [16], A solution of 1 
ml containing 5raM Ap4A, 1.0 M 2-chloroacetaldehyde 
and 50 mM amraonium acetate buffer, pH 4.5 was in- 
cubated at 35°C, Formation of etheno derivatives was 
followed by measuring the decrease of  the absorbance 
quotient A;:6s/,zt275; after about 70 h the quotient re- 
mained practically stable around 1.30. Analytical 
reversed-phase HPLC of the reaction mixture at dif- 
ferent incubation times revealed the progressive 
diminution of  the Ap4A peak (under UV detection)'and 
the simultaneous appearance of  a major and highly re- 
tained peak under both UV and fluorescence detection; 
other minor peaks were also evident (Fig. 1), The last 
peak of the chromatograms was tentatively identified as 
an etheno derivative of  Ap4A. This presumed etheno 
derivative was isolated from the reaction mixture as 
follows: 200 #1 aliquots of the mixture were diluted with 
water to 1 ml and applied to a Sep pak Accell QMA car- 
tridge; the cartridge was washed with 4 rnl of water and 
the nucleotides elated with 2 ml of  a Solution containing 
0.1 N HCI and 0.2 N KCl. The eluate was rapidly 
neutralized to pH 6 with 10 NKOH and injected into 
the chromatograph to collect the fluorescent derivative. 
1 
uv t ~ A~,~A 
10 t~ ~0 
fT~= ~t 
Fill. i. Chromatographic proril¢~(F,/'luorimetri¢= UV, ultraviolet)or 
the reaction nlixture of (.(Ap~A) synthesis after -/0 h reaction. Abonl 
~,:S% of Ap.:A was ~till presen|, Column: Liclwosorb C18, chroma. 
tographlc conditions according to section 2.2, 
Using a #Bondapak C-18 Column, quantities of 0.4-1.0 
mg could be isolated in one chromatographic run. 
Aliquots of  the HPLC-isolated fraction were sub- 
jected to  complete  enzymat ic  hydrolys is  by  C, durissus 
phospho.diesterase and then chromatographed; only 
one peak that co-elated with authentic e-AMP under 
both UV and fluorescence detection was obtained, this 
being consistent with an Ap4A derivative containing 
both adenine rings modified by a l,N~-etheno bridge; ~- 
(Ap4A) is the abbreviation proposed, for such com- 
pound; (Scheme I). 
3.2. Properties of ~-¢Ap4~,t) 
UV absorption spectra at neutral pH present two 
characteristic maxima at 265 and 274 nm and shoulders 
at ca 260 and 310 nm (Fig. 2). No changes were noticed 
in the pH range 6.0-8.0 when using phosphate or Tris 
buffers. Hydrolysis by C. durissus phosphodiesterase 
produced a slight hyperchromic effect (Fig, 2). By 
measuring the absorbance of  e-(Ap4A) at 265 nm before 
and after enzymatic hydrolysis and from the knowledge 
of  the molar absorption coefficient for e-AMP (6.0 × 
103M-t ,cm- :  [16] a value of 8.7 × 103M- : .cm-t  
was calculated for the molar absorption coefficient of  e- 
(Ap4A) at 265 nm. 
Upon excitation at 307 nm and neutral pH, E-(Ap4A) 
fluoresces with a maximum at 410 nm (Fig. 3), being the 
~ F'P P P~I  ~ 
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Fig. 2, Ultraviolet absorption spectra of ¢-(Ap.~A) in 50 mM Tris.HCl, 
4 mM MgCh, pl=l 8,0 before (--) and after (.-.-) hydrolysis by C, 
durlasus phosphodiesterase, 
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Fig, 3. Fluorescence emission spectra of ¢-(Ap4A) in 50 mM Tris-HC], 
4 mM MgCl2 pH 8.0 before (--) and after (--..) hydrolysis by C. 
durissus phosphodiesterase, 
fluorescent emission notoriously leas than that of ~- 
AMP,  this in spite of oantainin8 two e-AMP moteli~s, 
Hydrolysis or =-(Ap,~A) by C, duris~us phosphodiester- 
as¢ producefl a large increase of fluorescence emission, 
The maximum wavelength of emission w=s uncha~ged 
but an  intensity increase of 7.5 was measured (Fig. 3). 
So, enzyme splittin~ of  e-(A1hA), can be measured in a 
very sensible way by following the increase in 
fluorescence intensity with time at 410 nm. These 
fluorescence properties of e-(Al~A) appear to be similar 
to those reported for the ¢theno derivatives of  NaC* 
and are probably due to an intramotecular stacking of  
the het~rocyclic rings that produce an effective quen- 
ching of  fluorescence [17,I8]. No noticeable changes in 
fluoresceno: emission or c~citation were observecl per- 
forming hydrolysis in phosphate or Tris buffers. 
3.3. t-(Ap4A) as a substrate of  Ap4A cleaving enzymes 
Cleaving activities on Ap4A and other diadenosil~e 
polyphophates have been reported in cytosolic extracts 
from adreno-chromaffin tissue [8,19] and in the exter- 
nal surface of cultured chromaff in cells [22]. Conse- 
¢, AL'~P 
¢ - ADO 
6 " ~o 2'o 
Fig. 4. Fluorescence hromatographic profiles illustrating the ectoen- 
zymatic degradation f ~-(Ap4A) by cultured chromaffin ceils. 3 × 106 
c~lls/well were incubated at 37°C in 2.0 ml of Locke's olution con- 
taining 5 v.M e-(Ap4A); at the indicated times (A,O rain; B, 60 rain; 
C, 120 rain) 50/d were taken up and injected into the chromatograph. 
Column, ~Bondapak C18; chrorr.atographic conditions are according 
to section 2.2. 
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Fig. 5. Enzymatic degradation of =,(Ap~A) by a cytosolic extrac| from 
bovine adrenal medulla s a function of time, I-ml reaction mixtures 
were incubated and processed accordin8 to section 2,4, 50 Id aliquals 
were injected o~ to a ~Bondapak C.18 column according to section 
2.2, 
quently these biological sources were chosen to in- 
vestigate the usefulness o f  ~-(Ap4A) as a f luorogenic 
substrate for Ap ,A  cleaving enzymes, 
As shown in Figs 4 and 5 both intact cultured 
chromaf f in  cells and their cytosolic extracts were able 
to split e-(Ap4A) and then continue the degradation o f  
the e-nucleotide produced moieties up to e.Ado; the 
nucleoside accumulat ing in the medium.  This addi- 
t ionally indicates that ~-ATP. e-ADP and e-AMP are 
substrates o f  both ecto and cytosolic nucleotides. The 
presence and kinetic characterizat ion of  ec- 
tonucleotidases hydro lys ing  extracellular adenine 
nuc]eotides in chromaff in  cells has recently been 
publ ished [23]. The pattern of  e-nucleotide release from 
~-(Ap,=A) indicates an asymmetr ical  c eavage, similar to 
that o f  the unmodif ied nucleotide Ap4A [8,22]. 
K= values for Ap4A cleaving enzymes from bovine 
adrenal chromaff in  and aort ic endothelial cells lie in the 
low micromolar  range [8,22,24]. The results reported 
here demonstrate that e-(Ap4A) is biologically active at 
similar concentrat ions as is Ap4A, and open up the 
possibil ity to assay Ap4A cleaving enzymes by direct 
f luorescence measurements a a complementary  or even 
alternative approach to the use o f  radiometric or 
lurninometric techniques. It is noteworthy that e-Ado 
derived nucleotides can be f luorimetrical ly detected at 
concentrat ions as low as !0 -8  ~.  Another  interesting 
prOperw or  ~-(Ap~A) is that ~-Ado produced f rom it is 
not further catabol ized via adenosine deaminase 
because o f  the inab i l i ty  o f  this enzyme to  r¢coln ize ~- 
Ado as a subs/rate [25]; this allows, if desired, to fol low 
speci f ical ly  tile degradation o f  adenosine nucleoddes. 
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